Vaccinations

University of Oxford launches first human aerosol TB vaccine trial

The University of Oxford has commenced a new clinical trial called TB-45, which will test the safety of a new tuberculosis (TB) vaccine.

CureVac vaccine performs at 47% efficacy in latest trial

The German-made CureVac vaccine has given a result of 47% efficacy, much lower than expected - now, the proposed delivery of 225 million doses to the EU is at risk.

REACT study: Scientists say 90% of UK virus cases are Delta variant

The latest REACT figures show that 90% of UK virus cases are now the Delta variant, with the highest rates of infection in those...

COVID vaccines to be mandatory for care home workers

The UK Government will make COVID vaccination mandatory for care home workers, with the possibility that NHS workers will also be required to get the jab.

Delta variant twice as likely to cause COVID hospitalisation

A Scottish study, published in The Lancet, found the Delta variant was twice as likely as the Alpha variant to cause COVID hospitalisation.

PHE study finds AstraZeneca vaccine 92% effective against Delta variant

Public Health England found that two doses of the Pfizer and AstraZeneca vaccine could still keep patients with the Delta variant out of hospital - but both are now less able to stop infection in the first place.

European Commission launches EU Digital COVID Certificate

Today (14 June) the Commission formally signed legislation to create the EU Digital COVID Certificate - which will be used for 12 months, beginning from 1 July, 2021.

Study finds Novavax 93.2% effective against Alpha variant

A new study found that the Novavax vaccine was 93.2% effective against the Alpha variant - with no clarification about vaccine performance against the Delta variant.

G7 leaders agree to donate 8% of necessary COVID vaccines

The G7 meetings produced a new donation of 870 million COVID vaccines to struggling countries, with no progress on a waiver for vaccine patents.

Scientists identify gene that could protect against severe COVID

A team at Newcastle University have identified a gene, HLA-DRB1*04:01, which could be responsible for individuals who are asymptomatic - suggesting that the gene offers some protection against severe COVID.

Scientists say vaccines less effective against Delta variant

According to a new study, the antibodies created by the Pfizer vaccine are on average less effective against the Delta variant.

MHRA approves Pfizer vaccine for 12-15-year-olds

The Medicines and Healthcare products Regulatory Agency (MHRA) has concluded that the Pfizer/BioNTech COVID-19 vaccine is safe to use in 12-15-year-olds.

WHO gives emergency approval to Sinovac COVID-19 vaccine

The World Health Organisation (WHO) has given emergency approval to the Sinovac COVID-19 vaccine - because there is ongoing "access inequity" for countries in the Global South.

COVID-19 vaccines & genetic modification

Graham Brookes, Agricultural Economist with PG Economics, UK, charts how the development and deployment of COVID-19 vaccines, derived using techniques of genetic modification, highlight ideological inconsistency and hypocrisy.

UK approves use of single-dose Johnson & Johnson COVID vaccine

The UK today (28 May) approves use of the single-dose Johnson & Johnson vaccine that provides enough protection against the virus in one injection.

Scientists link AstraZeneca vaccine to arterial blood clots

Over the last three months, scientists have been tracing rare instances of blood clots in veins in connection to the AstraZeneca COVID vaccine - now, they have the first evidence of arterial blood clots, which can cause stroke.

What are the side effects of the Johnson & Johnson vaccine?

Here, we discuss some of the common misconceptions about side effects of the Johnson & Johnson COVID vaccine.

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders